When did Sight Sciences, Inc. report Q4 2024 earnings?

Sight Sciences, Inc. (SGHT) reported Q4 2024 earnings on March 5, 2025 after market close.

What were Sight Sciences, Inc.'s Q4 2024 revenue and EPS?

Sight Sciences, Inc. reported revenue of $19.1M and eps of $-0.23 for Q4 2024.

Did Sight Sciences, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $18.5M by $573.4K. EPS missed the consensus estimate of $-0.22 by $0.01.

Where can I find Sight Sciences, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-035500) directly on SEC EDGAR. The filing index links above go to sec.gov.

Sight Sciences, Inc. SGHT Q4 2024 Annual earnings

Reported March 5, 2025 · After market close

Revenue$19.1MBeat by $573.4K

EPS-$0.23Miss by $0.01

Revenue estimate$18.5M

EPS estimate-$0.22

Next report

Aug 5, 2026 (In 6 days)

Revenue estimate$21.7M

EPS estimate-$0.15

Financials

Q4 2024

Income statement

See full

Revenue$19.1M+1.7%

Gross profit$16.6M+3.7%

Operating income-$11.9M-7.4%

Net income-$11.8M-10.8%

EPS (diluted)-$0.24-9.1%

Balance sheet

See full

Cash & equivalents$120.4M-12.9%

Total debt$40.4M+14.0%

Total equity$87.5M-27.2%

Total assets$142.8M-14.3%

Cash flow

See full

Operating cash flow-$3.5M+46.7%

CapEx$137.0K-48.1%

Free cash flow-$3.6M+46.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$183.45M-27.3%

Enterprise value$103.45M-30.8%

P/S2.3×-0.8×

Profitability

See full

Gross margin85.5%+0.2pp

Operating margin-63.3%-6.0pp

Net margin-64.5%-3.6pp

FCF margin-28.9%-9.8pp

Returns & leverage

See full

Return on equity-49.6%+16.6pp

Debt / equity0.5×+0.2×

Current ratio9×-4.3×

Segments

By segment

See full

Surgical Glaucoma$18.8M+9.4%

Dry Eye$304.0K-81.0%

Versus estimates

Revenue

Q1 2026$19.7MBeat by $1.2M Q4 2025$20.4MBeat by $39.0K Q3 2025$19.9MMiss by $447.5K Q2 2025$19.6MBeat by $1.8M Q1 2025$17.5MMiss by $982.5K

Q4 2024$19.1MBeat by $573.4K

Diluted EPS

Q1 2026-$0.16Beat by $0.03 Q4 2025-$0.08Beat by $0.07 Q3 2025-$0.16Beat by $0.10 Q2 2025-$0.23Beat by $0.02 Q1 2025-$0.28Beat by $0.01

Q4 2024-$0.23Miss by $0.01

Ask the moment Sight Sciences, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Sight Sciences, Inc. report Q4 2024 earnings?: Sight Sciences, Inc. (SGHT) reported Q4 2024 earnings on March 5, 2025 after market close.
What were Sight Sciences, Inc.'s Q4 2024 revenue and EPS?: Sight Sciences, Inc. reported revenue of $19.1M and eps of $-0.23 for Q4 2024.
Did Sight Sciences, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $18.5M by $573.4K. EPS missed the consensus estimate of $-0.22 by $0.01.
Where can I find Sight Sciences, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-035500) directly on SEC EDGAR. The filing index links above go to sec.gov.